Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 114 results for "Aggressive B-Cell Lymphoma (ABCL)".

Thumbnail for Racial and Demographic Predictors of Time to Treatment Initiation and Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) :A Retrospective Cohort Study

ABCL - 885

Racial and Demographic Predictors of Time to Treatment Initiation and Survival Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) :A Retrospective Cohort Study

Aneeta Channar

Poster Presenter: Aneeta Channar

Thumbnail for Ribosomal Stoichiometric Reprogramming and Integrated Stress Response Activation Define a Translational Stalling State in DLBCL Non-Responder CAR-T Infusion Products

ABCL - 910

Ribosomal Stoichiometric Reprogramming and Integrated Stress Response Activation Define a Translational Stalling State in DLBCL Non-Responder CAR-T Infusion Products

Ali Turunc

Poster Presenter: Ali Turunc

Previous 1...10 11 12 13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

ABCL - 914

Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

Ali Turunc

Poster Presenter: Ali Turunc

$Thumbnail for Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis$

ABCL - 981

Comparative Efficacy and Safety of Available CD19-Directed Chimeric Antigen Receptor T-Cell Therapies for Treatment of Relapsed/Refractory Large B-Cell Lymphomas: A Network Meta-Analysis

Maryam Maqsood

Poster Presenter: Maryam Maqsood

$Thumbnail for Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial$

ABCL - 983

Zamtocabtagene Autoleucel, a Tandem CD20-CD19 CAR T-Cell Therapy in Relapsed/Refractory Large B-Cell Lymphoma: Third-Line Crossover Analysis From the Randomized DALY 2-EU Trial

Nirav Shah

Poster Presenter: Nirav Shah

Thumbnail for Impact of Statin Use on Treatment Response and Survival in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis of Cohort Studies

ABCL - 986

Impact of Statin Use on Treatment Response and Survival in Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis of Cohort Studies

April Joy Ong

Poster Presenter: April Joy Ong

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors